Paper96213
The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects.
Stephens MC and 4 others. J Neurochem, 1978. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects. Papers, record 96213. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/96213
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gaucher Disease | Major topic |
| Inositol | Major topic |
| Acetylglucosaminidase | |
| Animals | |
| Brain | |
| Cerebrosides | |
| Humans | |
| Liver | |
| Male | |
| Mice | |
| Spleen | |
| beta-Glucosidase |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41559755 | Constraint-based modelling of metabolic dysregulation in Gaucher disease: mitochondrial dysfunction and disrupted cholesterol homeostasis. | Orphanet J Rare Dis | 2026 | https://conductscience.org/library/papers/41559755 | PubMed |
| 41465340 | Refining Mouse Models of Gaucher Disease: Advancing Mechanistic Insights, Biomarker Discovery, and Therapeutic Strategies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465340 | PubMed |
| 38003227 | Animal Models for the Study of Gaucher Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003227 | PubMed |
| 37014126 | Glycosphingolipids within membrane contact sites influence their function as signaling hubs in neurodegenerative diseases. | FEBS Open Bio | 2023 | https://conductscience.org/library/papers/37014126 | PubMed |
| 30279220 | Distinguishing the differences in β-glycosylceramidase folds, dynamics, and actions informs therapeutic uses. | J Lipid Res | 2018 | https://conductscience.org/library/papers/30279220 | PubMed |
| 28701774 | Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis. | Sci Rep | 2017 | https://conductscience.org/library/papers/28701774 | PubMed |
| 28430167 | Induced Pluripotent Stem Cell Modeling of Gaucher's Disease: What Have We Learned? | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28430167 | PubMed |
| 26948439 | CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease. | Mol Ther | 2016 | https://conductscience.org/library/papers/26948439 | PubMed |
| 23880767 | β-Glucosidase 2 (GBA2) activity and imino sugar pharmacology. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23880767 | PubMed |
| 21954067 | Animal models for Gaucher disease research. | Dis Model Mech | 2011 | https://conductscience.org/library/papers/21954067 | PubMed |
| 15669681 | Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease. | J Inherit Metab Dis | 2004 | https://conductscience.org/library/papers/15669681 | PubMed |
| 8473508 | Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. | J Clin Invest | 1993 | https://conductscience.org/library/papers/8473508 | PubMed |
| 8163674 | Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. | J Clin Invest | 1994 | https://conductscience.org/library/papers/8163674 | PubMed |
| 6517862 | Characterization of the phospholipid requirement of a rat liver beta-glucosidase. | Biochem J | 1984 | https://conductscience.org/library/papers/6517862 | PubMed |
| 3099116 | Glucosylceramide and the level of the glucosidase-stimulating proteins. | Lipids | 1986 | https://conductscience.org/library/papers/3099116 | PubMed |
| 290986 | L-glucosylceramide: synthesis, properties, and resistance to catabolism by glucocerebrosidase in vitro. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/290986 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/96213
GET https://conductscience.org/api/papers/v1/96213/authors